News

Robust financial growth for Kiniksa Pharmaceuticals in Q2 2025, including 52% YoY ARCALYST revenue growth & raised guidance.
Synopsys, Inc. (SNPS) is currently at $646.13, up $53.50 or 9.03% --Would be new all-time high (Based on available data back to Feb. 26, 1992) --Would be the first new record closing high since July 5 ...
China's tighter rare earth export controls are disrupting Apple's plan to expand manufacturing in India as Dixon Technologies ...
July 26, 2025 - The increasing expansion of cloud-based solutions is significantly driving the revenue growth of the Software ...
Shares of Synopsys Inc. SNPS slid 1.33% to $601.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.40% to 6,388.64 and ...
We came across a bullish thesis on Cadence Design Systems, Inc. on Stock Analysis Compilation’s Substack. In this article, we ...
Meet the Newest Growth Stock Joining the S&P 500. It's Up 80% in 3 Months, and It's Still a Buy Right Now, According to Wall Street. Companies must meet certain criteria to qualify for inclusion in ...
Synopsys announced the completion of its acquisition of Ansys. The transaction, which was announced on January 16, 2024, ...
Synopsys (SNPS) has recently concluded its acquisition of Ansys, a move designed to fortify its position in silicon design and simulation. The company's stock experienced a notable increase of 43% ...
Synopsys has completed its acquisition of Ansys. First announced back in January 2024, the acquisition combines two companies ...
Cadence Design is a leader in electronic design automation, focused on digital and AI applications. Read more on what ...
TTD jumps 6.6% as it joins the S&P 500. The company expects CTV growth, Kokai demand and global ad trends to fuel momentum.